HOME >> BIOLOGY >> NEWS
Stepping up therapy for stroke and other CNS disorders

NEUROLOGY

Stroke is a major medical problem, with only very limited treatment options. In a study appearing online on July 7 in advance of print publication of the August 1 issue of the Journal of Clinical Investigation, Armin Schneider and colleagues from Axaron Biosciences describe new roles for granulocyte colony-stimulating factor (G-CSF) in treating stroke and other central nervous system roles of this protein.

The team reports that G-CSF has potent cell protective effects on mature neurons, explaining why it has been shown to be useful in animal stroke models. Moreover, G-CSF drives neuronal differentiation of adult neural stem cells in the brain, and has profound impact on long-term functional outcome after cerebral ischemia. The authors show that G-CSF itself is a neuronally expressed protein in the brain, and that systemic G-CSF can penetrate the intact blood-brain-barrier.

Thus, G-CSF is a potentially novel treatment for stroke and neurodegeneration. G-CSF doubles hippocampal neurogenesis even in normal, non-ischemic animals, making it a potential drug candidate for diseases where disturbances in neurogenesis are a factor.


'"/>

Contact: Stacie Bloom
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
7-Jul-2005


Page: 1

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... OTTAWA, Ontario (PRWEB) , ... ... ... creator of the world’s first on-site Legionella DNA test, today announced a ... commercial, and hospitality industries. , Through this strategic partnership, LiquiTech will integrate ...
(Date:7/5/2019)... ... 05, 2019 , ... SteriTrack Inc. is pleased to announce ... around the world. , Powered by Microsoft Azure, the Tractus™ software and ... operating theatres worldwide to address new global regulations mandating all medical devices and ...
(Date:6/19/2019)... ... ... Dahryn Trivedi, today released research results on the beneficial impact of biofield ... be beneficial for treating multiple bacterial diseases. , The preclinical trial shows:, ... decrease in weight , Over 8% alteration in melting point ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, ... the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production ... and commercialization rights to a full spectrum of botulinum neurotoxins, as well as ...
(Date:5/21/2019)... ADDIS ABABA, Ethiopia (PRWEB) , ... May 21, ... ... Lehranstalt für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing ... the brewing and malting industry in Africa. The event, which is supported through ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited ... website aims to improve LDA’s ability to communicate directly with the marketplace; serving ...
(Date:5/7/2019)... ... May 06, 2019 , ... ... for the growing number of repositories being asked to store cellular products ... the team of contributors who are world leaders, who have shared their expertise ...
Breaking Biology Technology:
Cached News: